Trial Search Results
Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704)
Prospective observational multicenter study of allogeneic Hematopoietic Stem Cell Transplantation (HCT) in recipients 60 years and older to assess important determinants of health status to be combined into a composite health risk model to improve risk assessment of non-relapse mortality (NRM).
Stanford is currently not accepting patients for this trial.
Center for International Blood and Marrow Transplant Research
Collaborator: National Institutes of Health (NIH)
- Diagnostic Test: Age 60+ with planned HCT for Hematologic Malignancy
1. Subject is > 60.0 years old at time of enrollment.
2. Hematological malignancy as an indication for allogeneic transplantation.
3. Eligible for allogeneic transplantation based on institutional standards
4. First allogeneic transplant planned. Any conditioning regimen and allogeneic donor is
5. Able to speak and read English. Spanish, and Mandarin will be acceptable when sites
have ability to perform healthcare provider tests in those languages.
6. Written informed consent
1. Prior allogeneic HCT
Ages Eligible for Study
60 Years - N/A
Genders Eligible for Study